Sun Pharma Advanced Research Company reports standalone net loss of Rs 99.65 crore in the December 2023 quarter
Sales decline 89.43% to Rs 13.86 crore
Net loss of Sun Pharma Advanced Research Company reported to Rs 99.65 crore in the quarter ended December 2023 as against net profit of Rs 10.15 crore during the previous quarter ended December 2022. Sales declined 89.43% to Rs 13.86 crore in the quarter ended December 2023 as against Rs 131.09 crore during the previous quarter ended December 2022. ParticularsQuarter EndedDec. 2023Dec. 2022% Var.Sales13.86131.09 -89 OPM %-740.4012.34 -PBDT-96.4913.28 PL PBT-99.6510.15 PL NP-99.6510.15 PLPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Feb 05 2024 | 2:52 PM IST